Haley is a clinical research professional with over 15 years of experience in drug development. While currently focused on rare disease feasibility and operational strategy Haley is experienced in clinical operations, regulatory affairs and project management across a wide range of therapeutic areas. Areas of special interest include pediatric clinical trials, gene therapy and decentralized trial implementation.
Haley Arellano
